Processa Pharmaceuticals, Inc. Business Finance Contracts & Agreements
40 Contracts & Agreements
- Credit Agreements (4 contracts)
- Equity Distribution Agreements (1)
- Loan Agreements (2)
- Note Agreements (4)
- Pledge Agreements (1)
- Purchase Agreements (9)
- Registration Rights Agreements (1)
- Share Agreements (2)
- Stock Agreements (2)
- Subordination Agreement (1)
- Underwriting Agreements (2)
- Warrant Agreements (11)
- Form of Securities Purchase Agreement, dated January 26, 2024, by and between Processa Pharmaceuticals, Inc. and each of the Purchasers (as defined therein) (Filed With SEC on January 30, 2024)
- Form of Placement Agent Warrant (Filed With SEC on January 30, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on January 30, 2024)
- Form of Common Warrant (Filed With SEC on January 30, 2024)
- Form of Securities Purchase Agreement (Filed With SEC on January 22, 2024)
- Form of Placement Agent Warrant (Filed With SEC on January 22, 2024)
- Form of Common Warrant (Filed With SEC on January 22, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on January 22, 2024)
- Form of Securities Purchase Agreement, dated February 9, 2023, by and between Processa Pharmaceuticals, Inc. and each of the Investors (as defined therein) (Filed With SEC on February 13, 2023)
- Registration Rights Agreement, dated March 23, 2022, by and between Processa Pharmaceuticals, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on March 24, 2022)
- Purchase Agreement, dated March 23, 2022, between Processa Pharmaceuticals, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on March 24, 2022)
- Equity Distribution Agreement, dated August 20, 2021, by and among Processa Pharmaceuticals, Inc. and Oppenheimer & Co. Inc (Filed With SEC on August 20, 2021)
- Form of Placement Agent Warrant (Filed With SEC on February 18, 2021)
- Securities Purchase Agreement dated February 16, 2021 (Filed With SEC on February 18, 2021)
- Underwriting Agreement, dated as of October 1, 2020, by and among the Company, Craig-Hallum Capital Group LLC and Benchmark Company, LLC, as representatives of several Underwriters (Filed With SEC on October 6, 2020)
- Share Issuance Agreement pursuant to License Agreement with Yuhan Corporation (Filed With SEC on September 17, 2020)
- Line of Credit Agreement dated September 20, 2019 between Processa Pharmaceuticals and CorLyst, LLC (Filed With SEC on September 17, 2020)
- Line of Credit Agreement dated September 20, 2019 between Processa Pharmaceuticals and DKBK Enterprises, LLC (Filed With SEC on September 17, 2020)
- Amendment to License Agreement and Securities Purchase Agreement with CoNCERT Pharmaceuticals (Filed With SEC on September 17, 2020)
- Form of Warrant (Filed With SEC on September 17, 2020)
- Form of Subscription Agreement for Senior Convertible Notes (Filed With SEC on September 17, 2020)
- Warrant issued to PoC Capital, LLC (Filed With SEC on September 17, 2020)
- Specimen of Common Stock Certificate (Filed With SEC on September 17, 2020)
- Asset Purchase Agreement. Dated October 2, 2017, among the Company, Promet Therapeutics LLC and Processa Therapeutics LLC (Filed With SEC on September 17, 2020)
- Form of Underwriting Agreement (Filed With SEC on September 17, 2020)
- Share Issuance Agreement by and between Processa Pharmaceuticals, Inc. and Yuhan Corporation, dated August 19, 2020 (Filed With SEC on August 20, 2020)
- Promissory Note, dated May 1, 2020, with Processa Pharmaceuticals, Inc. and Bank of America, N.A., received by the company under the Small Business Administration Paycheck... (Filed With SEC on July 17, 2020)
- Form of 8% Senior Convertible Notes (Filed With SEC on December 13, 2019)
- Line of Credit Agreement dated September 20, 2019 between Processa Pharmaceuticals and CorLyst, LLC (Filed With SEC on October 3, 2019)
- Line of Credit Agreement dated September 20, 2019 between Processa Pharmaceuticals and DKBK Enterprises, LLC (Filed With SEC on October 3, 2019)
- Pledge Agreement dated May 25, 2018, by and between Processa Pharmaceuticals, Inc. and PoC Capital, LLC (Filed With SEC on October 9, 2018)
- Form of Warrant (Filed With SEC on May 21, 2018)
- Form of Purchase Agreement (Filed With SEC on May 21, 2018)
- Convertible Note (Filed With SEC on April 16, 2018)
- Amendment to License Agreement and Securities Purchase Agreement with CoNCERT Pharmaceuticals (Filed With SEC on April 16, 2018)
- PROMISSORY NOTE EXTENSION AGREEMENT ADDENDUM TO NOTES UNDER LOAN AGREEMENT: SENIOR SECURED LOAN AGREEMENT 2.16.15 Extended to February 15, 2016 (Filed With SEC on August 19, 2015)
- HEATWURX, INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on March 27, 2014)
- CERTIFICATE OF DESIGNATIONS, PREFERENCES AND RIGHTS OF SERIES D 8% CONVERTIBLE PREFERRED STOCK OF HEATWURX, INC. (As amended on November 20, 2013) Pursuant to Section 151 of the... (Filed With SEC on March 27, 2014)
- SUBORDINATION AGREEMENT (Filed With SEC on May 23, 2013)
- SENIOR LOAN AGREEMENT (Filed With SEC on May 23, 2013)
